Advertisement
UK markets close in 2 hours 18 minutes
  • FTSE 100

    8,066.02
    +25.64 (+0.32%)
     
  • FTSE 250

    19,646.96
    -72.41 (-0.37%)
     
  • AIM

    753.90
    -0.79 (-0.10%)
     
  • GBP/EUR

    1.1668
    +0.0023 (+0.20%)
     
  • GBP/USD

    1.2464
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    50,508.73
    -2,471.52 (-4.66%)
     
  • CMC Crypto 200

    1,350.86
    -31.71 (-2.30%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     
  • GOLD FUTURES

    2,342.40
    +4.00 (+0.17%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,886.50
    -202.20 (-1.12%)
     
  • CAC 40

    7,977.71
    -114.15 (-1.41%)
     

IFF to buy Israel's Frutarom for $7.1 bln, nearing top spot

* Deal follows Givaudan (LSE: 0QPS.L - news) plan to launch offer for Naturex (Other OTC: NTUXY - news)

* Frutarom's largest shareholder to vote in favour

* Combined IFF-Frutarom revenue seen $5.3 bln in 2018

* Deal to close in 6-9 months, IFF (Paris: IFF.PA - news) to list shares in Tel Aviv (Adds Breakingviews link)

By Steven Scheer

JERUSALEM, May 7 (Reuters) - International Flavors & Fragrances Inc agreed to buy Israeli flavours and ingredients maker Frutarom for $7.1 billion in cash and stock on Monday, vying for the industry's top spot with market leader Givaudan.

The flavours and fragrances sector was expected to consolidate after Geneva-based Givaudan said in March it planned to launch an offer for French natural ingredients firm Naturex (EUREX: NATF.EX - news) and Israeli media reported last month that Frutarom had attracted takeover interest.

ADVERTISEMENT

IFF's takeover of Frutarom, which has been approved by both boards, would be the second largest of an Israeli company, behind Intel (Euronext: INCO.NX - news) 's $15 billion purchase of Mobileye (EUREX: MOEF.EX - news) .

"By combining our deep R&D expertise with Frutarom’s, we are offering our customers a broader range of solutions and accelerating our growth strategy," IFF CEO Andreas Fibig said.

Givaudan is expected to post revenue of 5.34 billion Swiss francs ($5.3 billion) this year, not yet taking Naturex into account, analyst estimates collected by Thomson Reuters (Dusseldorf: TOC.DU - news) show.

At present IFF is broadly on par in revenues with Germany's Symrise (IOB: 0G6T.IL - news) with 3.1 billion euros ($3.7 billion) in expected 2018 sales and unlisted Firmenich of Switzerland.

IFF said the acquisition unites two firms with complementary customers, capabilities and geographic reach that would result "in more exposure to fast growing end markets."

Under the terms of the IFF deal, Frutarom's shareholders will receive $71.19 in cash and 0.249 per share of IFF common stock for $106.25 per share.

IFF, which is paying an 11 percent premium to Frutarom's May 6 close, also will assume its net debt and the two companies are projected to have combined revenue of $5.3 billion in 2018.

ICC Industries Inc, Frutarom's largest shareholder with a 36 percent stake, forged a voting agreement with IFF and will vote in favour of the deal, IFF said.

It was not immediately clear how Fidelity Management and Research, the second largest stakeholder with 8.9 percent, will vote.

Frutarom sells more than 70,000 products, such as such as natural colours, health and beauty ingredients, natural food protection and enzymes, in 150 countries to mainly mid-sized companies.

Its largest customers include global names like Unilever (Amsterdam: UZ8.AS - news) , Nestle (Swiss: NESN.VX - news) and Coca Cola (NYSE: KO - news) as well as Israeli foodmaker Osem.

FASTER GROWTH

The companies said they expect to realise some $145 million of cost synergies by the third full year after closing, with about 25 percent achieved in the first full year. The deal is expected to be neutral to adjusted cash earnings per share in the first year and double-digit accretive to adjusted cash earnings per share in the second year.

The deal is expected to close in six to nine months, subject to various approvals, including by Frutarom's shareholders.

"We believe this combination will lead to faster and more profitable growth, enhanced free cash flow and generate greater returns for our shareholders," Fibig said.

IFF, which expects to maintain its quarterly dividend, said it will finance the cash portion of the transaction through a combination of existing cash on hand, new debt raised and about $2.2 billion in new equity. It said it had secured committed bridge financing from Morgan Stanley (Xetra: 885836 - news) .

Frutarom, with a market value of $5.7 billion and which targets annual revenue of $2.25 billion by 2020, has been growing through a steady stream of acquisitions in recent years, having bought 12 firms in 2017. More than 75 percent of its sales are in natural products.

Frutarom shares rose 2.6 percent in Tel Aviv. They are about 8 percent so far in 2018 after a 65 percent jump last year.

IFF will remain headquartered in New York and maintain a presence in Israel. IFF's shares will be listed on the New York Stock Exchange and the Tel Aviv Stock Exchange.

Frutarom CEO Ori Yehudai will be a strategic adviser to Fibig.

Greenhill & Co LLC and Morgan Stanley are serving as financial advisers to IFF, while BofA Merrill Lynch is advising Frutarom.

(Reporting by Steven Scheer; additional reporting by Ludwig Burger; editing by Alexander Smith and Jason Neely)